 | • レポートコード：QYR2104Z3505 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、リンパ腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（ホジキンリンパ腫、非ホジキンリンパ腫）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・リンパ腫治療の市場動向 ・企業の競争状況、市場シェア ・リンパ腫治療の種類別市場規模（経口、注射） ・リンパ腫治療の用途別市場規模（ホジキンリンパ腫、非ホジキンリンパ腫） ・リンパ腫治療の北米市場規模2016-2027（アメリカ、カナダ） ・リンパ腫治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・リンパ腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・リンパ腫治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・リンパ腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、CHIPSCREEN、Johnson & Johnson、Abbvie、Celgene） ・結論 |
Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes. These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. When you have lymphoma, lymphocytes change and grow out of control
Market Analysis and Insights: Global Lymphoma Therapy Market
The global Lymphoma Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lymphoma Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lymphoma Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lymphoma Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lymphoma Therapy market.
Global Lymphoma Therapy Scope and Market Size
Lymphoma Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lymphoma Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oral
Injection
Segment by Application
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
CHIPSCREEN
Johnson & Johnson
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lymphoma Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Lymphoma Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hodgkin Lymphoma
1.3.3 Non-Hodgkin Lymphoma
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Lymphoma Therapy Market Perspective (2016-2027)
2.2 Lymphoma Therapy Growth Trends by Regions
2.2.1 Lymphoma Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lymphoma Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Lymphoma Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Lymphoma Therapy Industry Dynamic
2.3.1 Lymphoma Therapy Market Trends
2.3.2 Lymphoma Therapy Market Drivers
2.3.3 Lymphoma Therapy Market Challenges
2.3.4 Lymphoma Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lymphoma Therapy Players by Revenue
3.1.1 Global Top Lymphoma Therapy Players by Revenue (2016-2021)
3.1.2 Global Lymphoma Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Lymphoma Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lymphoma Therapy Revenue
3.4 Global Lymphoma Therapy Market Concentration Ratio
3.4.1 Global Lymphoma Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lymphoma Therapy Revenue in 2020
3.5 Lymphoma Therapy Key Players Head office and Area Served
3.6 Key Players Lymphoma Therapy Product Solution and Service
3.7 Date of Enter into Lymphoma Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lymphoma Therapy Breakdown Data by Type
4.1 Global Lymphoma Therapy Historic Market Size by Type (2016-2021)
4.2 Global Lymphoma Therapy Forecasted Market Size by Type (2022-2027)
5 Lymphoma Therapy Breakdown Data by Application
5.1 Global Lymphoma Therapy Historic Market Size by Application (2016-2021)
5.2 Global Lymphoma Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Lymphoma Therapy Market Size (2016-2027)
6.2 North America Lymphoma Therapy Market Size by Type
6.2.1 North America Lymphoma Therapy Market Size by Type (2016-2021)
6.2.2 North America Lymphoma Therapy Market Size by Type (2022-2027)
6.2.3 North America Lymphoma Therapy Market Size by Type (2016-2027)
6.3 North America Lymphoma Therapy Market Size by Application
6.3.1 North America Lymphoma Therapy Market Size by Application (2016-2021)
6.3.2 North America Lymphoma Therapy Market Size by Application (2022-2027)
6.3.3 North America Lymphoma Therapy Market Size by Application (2016-2027)
6.4 North America Lymphoma Therapy Market Size by Country
6.4.1 North America Lymphoma Therapy Market Size by Country (2016-2021)
6.4.2 North America Lymphoma Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Lymphoma Therapy Market Size (2016-2027)
7.2 Europe Lymphoma Therapy Market Size by Type
7.2.1 Europe Lymphoma Therapy Market Size by Type (2016-2021)
7.2.2 Europe Lymphoma Therapy Market Size by Type (2022-2027)
7.2.3 Europe Lymphoma Therapy Market Size by Type (2016-2027)
7.3 Europe Lymphoma Therapy Market Size by Application
7.3.1 Europe Lymphoma Therapy Market Size by Application (2016-2021)
7.3.2 Europe Lymphoma Therapy Market Size by Application (2022-2027)
7.3.3 Europe Lymphoma Therapy Market Size by Application (2016-2027)
7.4 Europe Lymphoma Therapy Market Size by Country
7.4.1 Europe Lymphoma Therapy Market Size by Country (2016-2021)
7.4.2 Europe Lymphoma Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Lymphoma Therapy Market Size (2016-2027)
8.2 Asia-Pacific Lymphoma Therapy Market Size by Type
8.2.1 Asia-Pacific Lymphoma Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lymphoma Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lymphoma Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Lymphoma Therapy Market Size by Application
8.3.1 Asia-Pacific Lymphoma Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lymphoma Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lymphoma Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Lymphoma Therapy Market Size by Region
8.4.1 Asia-Pacific Lymphoma Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lymphoma Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Lymphoma Therapy Market Size (2016-2027)
9.2 Latin America Lymphoma Therapy Market Size by Type
9.2.1 Latin America Lymphoma Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Lymphoma Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Lymphoma Therapy Market Size by Type (2016-2027)
9.3 Latin America Lymphoma Therapy Market Size by Application
9.3.1 Latin America Lymphoma Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Lymphoma Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Lymphoma Therapy Market Size by Application (2016-2027)
9.4 Latin America Lymphoma Therapy Market Size by Country
9.4.1 Latin America Lymphoma Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Lymphoma Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lymphoma Therapy Market Size (2016-2027)
10.2 Middle East & Africa Lymphoma Therapy Market Size by Type
10.2.1 Middle East & Africa Lymphoma Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lymphoma Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lymphoma Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Lymphoma Therapy Market Size by Application
10.3.1 Middle East & Africa Lymphoma Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lymphoma Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lymphoma Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Lymphoma Therapy Market Size by Country
10.4.1 Middle East & Africa Lymphoma Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lymphoma Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Lymphoma Therapy Introduction
11.1.4 Roche Revenue in Lymphoma Therapy Business (2016-2021)
11.1.5 Roche Recent Development
11.2 CHIPSCREEN
11.2.1 CHIPSCREEN Company Details
11.2.2 CHIPSCREEN Business Overview
11.2.3 CHIPSCREEN Lymphoma Therapy Introduction
11.2.4 CHIPSCREEN Revenue in Lymphoma Therapy Business (2016-2021)
11.2.5 CHIPSCREEN Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Lymphoma Therapy Introduction
11.3.4 Johnson & Johnson Revenue in Lymphoma Therapy Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Abbvie
11.4.1 Abbvie Company Details
11.4.2 Abbvie Business Overview
11.4.3 Abbvie Lymphoma Therapy Introduction
11.4.4 Abbvie Revenue in Lymphoma Therapy Business (2016-2021)
11.4.5 Abbvie Recent Development
11.5 Celgene
11.5.1 Celgene Company Details
11.5.2 Celgene Business Overview
11.5.3 Celgene Lymphoma Therapy Introduction
11.5.4 Celgene Revenue in Lymphoma Therapy Business (2016-2021)
11.5.5 Celgene Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Lymphoma Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Lymphoma Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Lymphoma Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Lymphoma Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Lymphoma Therapy Market Share by Regions (2016-2021)
Table 8. Global Lymphoma Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Lymphoma Therapy Market Share by Regions (2022-2027)
Table 10. Lymphoma Therapy Market Trends
Table 11. Lymphoma Therapy Market Drivers
Table 12. Lymphoma Therapy Market Challenges
Table 13. Lymphoma Therapy Market Restraints
Table 14. Global Lymphoma Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Lymphoma Therapy Market Share by Players (2016-2021)
Table 16. Global Top Lymphoma Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lymphoma Therapy as of 2020)
Table 17. Ranking of Global Top Lymphoma Therapy Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Lymphoma Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Lymphoma Therapy Product Solution and Service
Table 21. Date of Enter into Lymphoma Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Lymphoma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Lymphoma Therapy Revenue Market Share by Type (2016-2021)
Table 25. Global Lymphoma Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Lymphoma Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Lymphoma Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Lymphoma Therapy Revenue Market Share by Application (2016-2021)
Table 29. Global Lymphoma Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Lymphoma Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Lymphoma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Lymphoma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Lymphoma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Lymphoma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Lymphoma Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Lymphoma Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Lymphoma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Lymphoma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Lymphoma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Lymphoma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Lymphoma Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Lymphoma Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Lymphoma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Lymphoma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Lymphoma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Lymphoma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Lymphoma Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Lymphoma Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Lymphoma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Lymphoma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Lymphoma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Lymphoma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Lymphoma Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Lymphoma Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Lymphoma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Lymphoma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Lymphoma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Lymphoma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Lymphoma Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Lymphoma Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. Roche Company Details
Table 62. Roche Business Overview
Table 63. Roche Lymphoma Therapy Product
Table 64. Roche Revenue in Lymphoma Therapy Business (2016-2021) & (US$ Million)
Table 65. Roche Recent Development
Table 66. CHIPSCREEN Company Details
Table 67. CHIPSCREEN Business Overview
Table 68. CHIPSCREEN Lymphoma Therapy Product
Table 69. CHIPSCREEN Revenue in Lymphoma Therapy Business (2016-2021) & (US$ Million)
Table 70. CHIPSCREEN Recent Development
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Lymphoma Therapy Product
Table 74. Johnson & Johnson Revenue in Lymphoma Therapy Business (2016-2021) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Abbvie Company Details
Table 77. Abbvie Business Overview
Table 78. Abbvie Lymphoma Therapy Product
Table 79. Abbvie Revenue in Lymphoma Therapy Business (2016-2021) & (US$ Million)
Table 80. Abbvie Recent Development
Table 81. Celgene Company Details
Table 82. Celgene Business Overview
Table 83. Celgene Lymphoma Therapy Product
Table 84. Celgene Revenue in Lymphoma Therapy Business (2016-2021) & (US$ Million)
Table 85. Celgene Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lymphoma Therapy Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Global Lymphoma Therapy Market Share by Application: 2020 VS 2027
Figure 5. Hodgkin Lymphoma Case Studies
Figure 6. Non-Hodgkin Lymphoma Case Studies
Figure 7. Lymphoma Therapy Report Years Considered
Figure 8. Global Lymphoma Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Lymphoma Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Lymphoma Therapy Market Share by Regions: 2020 VS 2027
Figure 11. Global Lymphoma Therapy Market Share by Regions (2022-2027)
Figure 12. Global Lymphoma Therapy Market Share by Players in 2020
Figure 13. Global Top Lymphoma Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lymphoma Therapy as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Lymphoma Therapy Revenue in 2020
Figure 15. Global Lymphoma Therapy Revenue Market Share by Type (2016-2021)
Figure 16. Global Lymphoma Therapy Revenue Market Share by Type (2022-2027)
Figure 17. North America Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Lymphoma Therapy Market Share by Type (2016-2027)
Figure 19. North America Lymphoma Therapy Market Share by Application (2016-2027)
Figure 20. North America Lymphoma Therapy Market Share by Country (2016-2027)
Figure 21. United States Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Lymphoma Therapy Market Share by Type (2016-2027)
Figure 25. Europe Lymphoma Therapy Market Share by Application (2016-2027)
Figure 26. Europe Lymphoma Therapy Market Share by Country (2016-2027)
Figure 27. Germany Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Lymphoma Therapy Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Lymphoma Therapy Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Lymphoma Therapy Market Share by Region (2016-2027)
Figure 37. China Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Lymphoma Therapy Market Share by Type (2016-2027)
Figure 45. Latin America Lymphoma Therapy Market Share by Application (2016-2027)
Figure 46. Latin America Lymphoma Therapy Market Share by Country (2016-2027)
Figure 47. Mexico Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Lymphoma Therapy Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Lymphoma Therapy Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Lymphoma Therapy Market Share by Country (2016-2027)
Figure 53. Turkey Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Lymphoma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Roche Revenue Growth Rate in Lymphoma Therapy Business (2016-2021)
Figure 57. CHIPSCREEN Revenue Growth Rate in Lymphoma Therapy Business (2016-2021)
Figure 58. Johnson & Johnson Revenue Growth Rate in Lymphoma Therapy Business (2016-2021)
Figure 59. Abbvie Revenue Growth Rate in Lymphoma Therapy Business (2016-2021)
Figure 60. Celgene Revenue Growth Rate in Lymphoma Therapy Business (2016-2021)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
世界の非ホジキンリンパ腫（NHL）市場規模・現状・予測（2021年-2027年） Non-Hodgkin Lymphoma is the most common lymphoma which affects large number of people. It begins in lymphocytes present in lymph nodes of body parts such as neck or chest or under the arms. It widely spreads to the other lymph nodes and to other organs such as bone marrow, lungs, or liver. Market An…- 世界のホジキンリンパ腫治療市場規模・現状・予測（2021年-2027年） Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system. In HL, cells in the l…
- 世界の非ホジキンリンパ腫治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Non-Hodgkin Lymphoma Therapeutics Market The global Non-Hodgkin Lymphoma Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
- 世界のホジキンリンパ腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hodgkin Lymphoma Treatment Market The global Hodgkin Lymphoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …
- 世界の非ホジキンリンパ腫治療薬市場 2021：企業別、地域別、種類・用途別 The Non-Hodgkin Lymphoma Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…